Global Biomarkers Market (2018-2025) Advancing In Medical Consumables Industry With Bio-Rad Laboratories, PerkinElmer, Inc., QIAGEN and More

A blend of top-down and bottom-up approaches were used to come to the exact market sizes and development rates of the global Biomarker market and its segments. Various secondary information sources were used to find the overall revenues, product portfolios and geographic reach of the companies operating in the Biomarker market. Estimates of the solution, services and Biomarker deployment type classification revenues were confirmed and validated through primary interviews. Primary interviews are conducted with various players in Biomarker ecosystem and key opinion leaders to confirm the provided percentage split and market share. The study demonstrates key market dynamics that are expected to influence the current environment and future status of global market over the forecast period.

 
The Global Biomarkers Market is expected to reach USD 85,927.95 million by 2024, from USD 28,091.78 million in 2016 growing at a CAGR of 15.1% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The factors such as increased usage of biomarkers in cancer treatment, growing efforts towards drug discovery, wide application of biomarkers in personalized medicine and diagnostics, initiatives taken towards biomarker research are furthermore boosting the growth of the global biomarkers market. On the other hand, high capital investment may hinder the growth of the market. The biomarker market in the Global region is leading in North America.

Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market

Key Points: Global Biomarkers Market

Global biomarkers market is dominated by Bio-Rad Laboratories, Inc., followed by Perkin Elmer, Inc. and Qiagen.

Consumables segment is expected to dominate the Global biomarkers market.

The biomarkers market in the Global region is leading in North America, Europe, Asia-Pacific accounts for the highest market share in this region.
 

Market Segmentation: Global Biomarkers Market

The global biomarker market is segmented on the basis of product type, technology, application and indication. The global biomarkers market is segmented based on product type into three notable segments; consumables, services and software. In 2017, consumables segment is expected to dominate the global biomarkers market with 58.6% market share and is expected to reach USD 51,156.05 million by 2024, with the highest CAGR of 15.4% in the forecast period 2017 to 2024.

On the basis of technology, global biomarker market is segmented into three notable segments; safety biomarkers, efficacy biomarkers and validation biomarkers. In 2017, safety biomarkers is expected to dominate the global biomarkers market with 47.8% market share and is expected to reach USD  41,933.30 million by 2024, with the highest CAGR of 15.4% in the forecast period 2017 to 2024.

On the basis of application, global biomarker market is segmented into diagnostics development, drug discovery and development, personalized medicine, disease-risk assessment, and others. In 2017, diagnostic development is expected to dominate the market with the market share of 35.4% the market is expected to reach USD 29,148.7 million by 2024, growing at a CAGR of 14.4% in the forecast period 2017 to 2024. However, personalized medicine is expected to grow at the highest CAGR of 16.2% in the forecast period, and is expected to reach USD 19,520.5 million in 2024 from USD 5,901.5 million in 2016.

The Global biomarkers market is segmented based on indication into four notable segments; cancer, cardiovascular disorders, neurological disorders, immunological disorders, and others diseases. In 2017, cancer is expected to dominate the global biomarkers market with 38.0% market share and is expected to reach USD 32,632.11 million by 2024, with a CAGR of 15.1% in the forecast period 2017 to 2024.  However, cardiovascular disorders is expected to grow at the highest CAGR of 15.9% in the forecast period, and is expected to reach USD 25,063.53 million in 2024 from USD 7,736.13 million in 2016
 

BIO-RAD LABORATORIES INC.:

Bio-rad has its presence across the globe in United States, Australia, Greece, Portugal, Austria, Hong Kong, Russia, Belgium, France, Hungary, South Africa, Singapore, Brazil, India, Canada, Israel, South Korea, China, Italy, Spain, Czech Republic, Japan, Sweden, Denmark, Netherlands, Mexico, Switzerland, Egypt, Taiwan, Finland, New Zealand, Thailand, Norway, United Kingdom, Germany, and Poland.

PERKINELMER INC.:

PerkinElmer develops, manufactures and markets a broad range of branded, generic and branded generic pharmaceutical products which are marketed directly or indirectly in U.S. and across the globe. The company commercializes products and services in over 150 countries.

QIAGEN:-

Qiagen has its operations across the North America, Europe, Middle East and Africa, Asia-Pacific and rest of world. Some of its subsidiaries include Exiqon (Denmark), Cellestis (Australia), Tiangen Biotech Co. Ltd. (Beijing), Qiagen Ltd. (India), Ipsogen SA (France) and many more subsidiaries across the globe.

Full Report Description Or Requesting TOC, Visit:   http://databridgemarketresearch.com/reports/global-biomarkers-market/

Key Drivers: Global Biomarkers Market

Global biomarker market is growing with the increased usage of biomarkers in cancer treatment, growing efforts towards drug discovery, wide application of biomarkers in personalized medicine and diagnostics, initiatives taken towards biomarker research are furthermore boosting the growth of the global biomarkers market.

Table Of Contents

Introduction
1.1.      Objectives Of The Study       

1.2.      Market Definition      

1.3.      Overview Of Global Biomarkers Market      

1.4.      Currency And Pricing

1.5.      Limitation

1.6.      Markets Covered       

Market Segmentation
2.1.      Markets Covered       

2.2.      Geographic Scope      

2.3.      Years Considered For The Study      

2.4.      Currency And Pricing

2.5.      Research Methodology          

2.6.      Primary Interviews With Key Opinion Leaders        

2.7.      Secondary Sources     

2.8.      Assumptions  

Market Overview
3.1.      Drivers           

3.1.1.   Increased Usage Of Biomarkers In Cancer Treatment          

3.1.2.   Growing Efforts Towards Drug Discovery   

3.1.3.   Wide Application Of Biomarkers In Personalized Medicine And Diagnostics        

3.1.4.   Initiatives Taken Towards Biomarker Research        

3.2.      Restraints       

3.2.1.   Unfavourable Reimbursement Systems         

3.2.2.   High Capital Investments      

3.2.3.   High Costing Involved In Sample Collection And Storage  

3.3.      Opportunities 

3.3.1.   Emerging Economies 

3.4.      Challenges

3.4.1.   Demonstrating The Clinical Validity In Biomarker-Based Tests      

Executive Summary
Premium Insights

Continue…

Want Full Report? Inquire For Buy: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biomarkers-market

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization or Getting Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.